Medical News Summary: Pfizer releases Bextra risks information
About: Pfizer releases Bextra risks information
Date: 11 December 2004
Source: Canada Newswire
Medical News Summary (summary of medical news story as reported by Canada Newswire): Pfizer had recently sent out an information letter detailing the risks involved with Bextra use. Bextra is used to treat osteoarthritis, adult rheumatoid arthritis and menstrual cramping pain. Pfizer states that the drug shouldn’t be used prior to or following surgery if it can be avoided due to risk of cardiovascular events such as heart attacks and strokes, lung blood clots, leg blood clots and infections. Bextra may also have the side effect of serious skin reactions such as toxic epidermal necrolysis, Stevens-Johnson Syndrome and erythema multiforme. Some of these conditions may lead to death. Bextra use should be discontinued if the patient develops a skin rash, mucosal lesions, mouth sores, breathlessness, wheezing, chest tightness or an allergic reaction. Some of these conditions may require urgent medical attention.
URL: http://www.newswire.ca/en/releases/archive/December2004/10/c4297.html
Related Disease Topics: Osteoarthritis, Adult rheumatoid arthritis, Menstrual cramping pain, Cardiovascular disease, Heart attack, Stroke, Blood clot in lung, Blood clot in let, Infection, Toxic epidermal necrolysis, Stevens-Johnson Syndrome, Erythema multiforme, Skin rash, Mucosal lesions, Mouth sores, Breathlessness, Wheezing, Chest tightness (see Chest pressure), Allergic reaction (type of Adverse reaction)
Related Medical News Channels: This medical news summary article refers to the following medical channel categories:
- Death from toxic epidermal necrolysis
- Death from Stevens-Johnson Syndrome and erythema multiforme
- cause of cardiovascular disease
- cause of heart attack
- cause of stroke
- Cause of blood clot in lung
- Cause of blood clot in let
- cause of infection
- Cause of toxic epidermal necrolysis
- cause of Stevens-Johnson Syndrome
- cause of erythema multiforme
- cause of skin rash
- Cause of mucosal lesions
- cause of mouth sores
- cause of breathlessness
- cause of wheezing
- cause of chest tightness
- cause of allergic reaction
- risk and cardiovascular disease
- risk and heart attack
- risk and stroke
- Risk and blood clot in lung
- Risk and blood clot in let
- Risk and infection
- Risk and toxic epidermal necrolysis
- risk and Stevens-Johnson Syndrome
- risk and erythema multiforme
- risk and skin rash
- Risk and mucosal lesions
- risk and mouth sores
- Risk and breathlessness
- risk and wheezing
- Risk and chest tightness
- risk and allergic reaction
- medication and osteoarthritis
- medication and adult rheumatoid arthritis
- Medication and menstrual cramping pain
- medication and cardiovascular disease
- medication and heart attack
- medication and stroke
- Medication and blood clot in lung
- Medication and blood clot in let
- medication and infection
- Medication and toxic epidermal necrolysis
- medication and Stevens-Johnson Syndrome
- medication and erythema multiforme
- medication and skin rash
- Medication and mucosal lesions
- medication and mouth sores
- medication and breathlessness
- medication and wheezing
- medication and chest tightness
- medication and allergic reaction
Medical Tools & Articles:
Next articles:
Medical Articles: